New phenylalkylamines and their use in the treatment of psychiatric disorders

Abstract

This disclosure provides information on phenalkylamine compounds and their use in the treatment of medical conditions, such as psychiatric illnesses and disorders. Pharmaceutical compositions and methods for manufacturing various phenalkylamine compounds are provided. Methods for treating a psychiatric illness or disorder are also disclosed herein, comprising administering to a patient in need thereof a therapeutically effective amount of any of the therapeutic compounds described herein or a pharmaceutical composition containing the therapeutic compound.